Avoro Capital Advisors WHWK Position
Active6-Fund ConvergenceAvoro Capital Advisors held their position in Whitehawk Therapeutics, Inc. (WHWK) in Q4 2025, holding $6.9M worth of shares across 2,849,402 shares.
The position was first reported in Q1 2023 and has been tracked across 12 quarterly 13F filings.
WHWK is a convergence signal: 6 specialist biotech funds hold this stock, suggesting high institutional conviction.
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
Full company profile →Short Interest
2.0%
4.3 days to cover
Avoro Capital Advisors WHWK Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Held | 2,849,402 | — | $6.9M |
| Q3 2025 | Held | 2,849,402 | — | $5.4M |
| Q2 2025 | Held | 2,849,402 | — | $5.3M |
| Q1 2025 | Held | 2,849,402 | — | $5.1M |
| Q4 2024 | Held | 2,849,402 | — | $9.0M |
| Q3 2024 | Held | 2,849,402 | — | $5.9M |
| Q2 2024 | Held | 2,849,402 | — | $4.2M |
| Q1 2024 | Held | 2,849,402 | — | $6.7M |
| Q4 2023 | Held | 2,849,402 | — | $5.8M |
| Q3 2023 | Held | 2,849,402 | — | $13.8M |
| Q2 2023 | Held | 2,849,402 | — | $19.5M |
| Q1 2023 | New | 2,849,402 | +2,849,402 | $20.6M |
Frequently Asked Questions
Does Avoro Capital Advisors own WHWK?
Yes. As of Q4 2025, Avoro Capital Advisors holds 2,849,402 shares of Whitehawk Therapeutics, Inc. (WHWK) valued at $6.9M. This data comes from their SEC 13F filing.
How many hedge funds own WHWK?
6 specialist biotech hedge funds currently hold WHWK, including OrbiMed Advisors, Baker Bros. Advisors, RA Capital Management and 2 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Avoro Capital Advisors first buy WHWK?
Avoro Capital Advisors's position in WHWK was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Avoro Capital Advisors's WHWK position increasing or decreasing?
Avoro Capital Advisors held their WHWK position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
WHWKCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Avoro Capital AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →